Cargando…

Ferroportin and FBXL5 as Prognostic Markers in Advanced Stage Clear Cell Renal Cell Carcinoma

PURPOSE: Advanced stage clear cell renal cell carcinoma (ccRCC) involves a poor prognosis. Several studies have reported that dysfunctions in iron metabolism–related proteins may cause tumor progression and metastasis of this carcinoma. In this study, we investigated the impact of the expression of...

Descripción completa

Detalles Bibliográficos
Autores principales:	Park, Cheol Keun, Heo, Jayoon, Ham, Won Sik, Choi, Young-Deuk, Shin, Sang Joon, Cho, Nam Hoon
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Korean Cancer Association 2021
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8524006/ https://www.ncbi.nlm.nih.gov/pubmed/33735560 http://dx.doi.org/10.4143/crt.2021.031

Ejemplares similares

FBXL6 depletion restrains clear cell renal cell carcinoma progression
por: Yu, Yongchun, et al.
Publicado: (2022)

Risk Prediction Tool for Aggressive Tumors in Clinical T1 Stage Clear Cell Renal Cell Carcinoma Using Molecular Biomarkers
por: Park, Jee Soo, et al.
Publicado: (2019)

Gene Expression Analysis of Aggressive Clinical T1 Stage Clear Cell Renal Cell Carcinoma for Identifying Potential Diagnostic and Prognostic Biomarkers
por: Park, Jee Soo, et al.
Publicado: (2020)

Ferroportin and Erythroid Cells: An Update
por: Cianetti, Luciano, et al.
Publicado: (2010)

Human macrophage ferroportin biology and the basis for the ferroportin disease
por: Sabelli, Manuela, et al.
Publicado: (2017)

Predictive value of preoperative monocyte–lymphocyte ratio among patients with localized clear renal cell carcinoma of ≤7 cm on preoperative imaging
por: Elghiaty, Ahmed, et al.
Publicado: (2018)

Pediatric Ferroportin Disease
por: Galicia-Poblet, Gonzalo, et al.
Publicado: (2016)

Review of Prognostic Expression Markers for Clear Cell Renal Cell Carcinoma
por: Petitprez, Florent, et al.
Publicado: (2021)

A Comprehensive Prognostic Stratification for Patients with Metastatic Renal Clear Cell Carcinoma
por: Cho, Kang Su, et al.
Publicado: (2008)

Identifying TYMP as an Immune Prognostic Marker in Clear Cell Renal Cell Carcinoma
por: Chen, Shao-An, et al.
Publicado: (2023)

The hepcidin-ferroportin axis controls the iron content of Salmonella-containing vacuoles in macrophages
por: Lim, Daejin, et al.
Publicado: (2018)

Revisiting extraprostatic extension based on invasion depth and number for new algorithm for substaging of pT3a prostate cancer
por: Park, Cheol Keun, et al.
Publicado: (2021)

Notch and the pre-TCR coordinate thymocyte proliferation by induction of the SCF subunits Fbxl1 and Fbxl12
por: Zhao, Bin, et al.
Publicado: (2019)

A disease-causing mutation K240E disrupts ferroportin trafficking by SUMO (ferroportin SUMOylation)
por: Bayele, Henry K., et al.
Publicado: (2021)

Macrophage ferroportin is essential for stromal cell proliferation in wound healing
por: Recalcati, Stefania, et al.
Publicado: (2019)

FOXC2 and CLIP4 : a potential biomarker for synchronous metastasis of ≤7-cm clear cell renal cell carcinomas
por: Ahn, Jinwoo, et al.
Publicado: (2016)

IMP3, a Promising Prognostic Marker in Clear Cell Renal Cell Carcinoma
por: Park, Ji Young, et al.
Publicado: (2014)

Piwi-interacting RNAs as novel prognostic markers in clear cell renal cell carcinomas
por: Busch, Jonas, et al.
Publicado: (2015)

Prognostic value of epithelial-mesenchymal transition markers in clear cell renal cell carcinoma
por: Xu, Hua, et al.
Publicado: (2020)

Stage-dependent prognostic impact of molecular signatures in clear cell renal cell carcinoma
por: Weber, Thomas, et al.
Publicado: (2014)

Ferroportin in the progression and prognosis of hepatocellular carcinoma
por: Wang, Qin, et al.
Publicado: (2013)

Ferroportin disease: pathogenesis, diagnosis and treatment
por: Pietrangelo, Antonello
Publicado: (2017)

Pharmacological Targeting of the Hepcidin/Ferroportin Axis
por: Sebastiani, Giada, et al.
Publicado: (2016)

Decreased expression of ferroportin in prostate cancer
por: Xue, Dong, et al.
Publicado: (2021)

Isolation and thermal stabilization of mouse ferroportin
por: Deshpande, Chandrika N., et al.
Publicado: (2020)

Mechanism of Ca(2+) transport by ferroportin
por: Shen, Jiemin, et al.
Publicado: (2023)

Scale-Up Evaluation of a Composite Tumor Marker Assay for the Early Detection of Renal Cell Carcinoma
por: Kim, Dong Su, et al.
Publicado: (2020)

Construction of five microRNAs prognostic markers and a prognostic model for clear cell renal cell carcinoma
por: Zhou, Qi, et al.
Publicado: (2021)

F-box protein Fbxl18 mediates polyubiquitylation and proteasomal degradation of the pro-apoptotic SCF subunit Fbxl7
por: Liu, Y, et al.
Publicado: (2015)

Lactate Dehydrogenase A is a potential prognostic marker in clear cell renal cell carcinoma
por: Girgis, Hala, et al.
Publicado: (2014)

Extracellular miR-224 as a prognostic marker for clear cell renal cell carcinoma
por: Fujii, Nakanori, et al.
Publicado: (2017)

Analysis of various potential prognostic markers and survival data in clear cell renal cell carcinoma
por: Ebru, Tastekin, et al.
Publicado: (2017)

The Genes—Candidates for Prognostic Markers of Metastasis by Expression Level in Clear Cell Renal Cell Cancer
por: Apanovich, Natalya, et al.
Publicado: (2020)

GABRQ expression is a potential prognostic marker for patients with clear cell renal cell carcinoma
por: Lee, Dongjun, et al.
Publicado: (2019)

Comprehensive analysis of the collagen family members as prognostic markers in clear cell renal cell carcinoma
por: Guo, Lingyu, et al.
Publicado: (2022)

FAM72 family proteins as poor prognostic markers in clear cell renal carcinoma
por: Gou, Hui, et al.
Publicado: (2023)

Metabolic tumour volume on (18)F-FDG PET/CT predicts extended pathological T stages in patients with renal cell carcinoma at staging
por: Kim, Dongwoo, et al.
Publicado: (2021)

Epigenetic suppression of FBXL7 promotes metastasis
por: Moro, Loredana, et al.
Publicado: (2020)

Therapeutic Advances in Regulating the Hepcidin/Ferroportin Axis
por: Hawula, Zachary J., et al.
Publicado: (2019)

Structural basis of ion transport and inhibition in ferroportin
por: Pan, Yaping, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_a1ngt733v97otfohpbg1q89i3n